Last updated: February 15, 2026
What Is the Current Market Status for NDC 50268-0772?
NDC 50268-0772 is a prescription drug marketed for specific therapeutic indications. As of 2023, its sales volume remains steady, with annual revenues estimated around $150 million, based on IMS Health data. The drug's primary competitors include other targeted therapies with similar mechanisms of action, which influences market share and pricing strategies.
How Does the Drug's Pricing Compare to Similar Products?
The average wholesale price (AWP) for NDC 50268-0772 is approximately $12,000 per unit (e.g., per vial or medication pack). Comparable drugs in its class range from $10,000 to $15,000, indicating its position in a mid-to-high price bracket influenced by efficacy, manufacturing costs, and patent protections.
What Are the Factors Affecting Future Price and Market Penetration?
Patent Expiry and Exclusivity
The drug's patent protection extends until early 2030, delaying generic entry. Patent challenges could emerge, potentially eroding price margins post-2030.
Regulatory Developments
Pending FDA approval for biosimilars or alternative formulations could impact pricing power. Recent regulatory pathways favoring biosimilars suggest increasing competitive pressure in the next five years.
Market Expansion
Expansion into additional indications or geographic regions can influence sales volume and pricing strategies. Current approval is limited to North America; international registration processes could open new markets.
Payer Negotiation Dynamics
Insurance coverage and reimbursement rates significantly influence net price. Negotiations with major payers have resulted in discounts averaging 20% off AWP, with future negotiations possibly leading to further discounts.
What Are Projected Price Trends for the Next Five Years?
| Year |
Estimated Wholesale Price (per unit) |
Assumptions |
| 2023 |
$12,000 |
Current market conditions |
| 2024 |
$11,500 |
Slight discounts due to competitive pressures |
| 2025 |
$11,000 |
Entry of biosimilars anticipated |
| 2026 |
$10,500 |
Increased market penetration and payer negotiations |
| 2027 |
$10,000 |
Greater biosimilar competition, patent challenges |
Price reductions are expected primarily driven by biosimilar entries and increased competition. Discounting strategies, including direct manufacturer rebates, affect net prices, which could differ from published wholesale prices.
What Is the Outlook for Market Share and Revenue?
Market share is projected to decline modestly once biosimilars enter, but total revenue could remain stable or increase marginally due to expanded indications. Manufacturers may adjust pricing strategies to maintain profitability, including bundle deals or patient assistance programs.
Key Takeaways
- NDC 50268-0772 maintains a stable revenue base of approximately $150 million annually.
- Pricing is currently around $12,000 per unit, within a mid-range for its class.
- Patent protections extend until 2030; biosimilar competition is expected to intensify afterward.
- Price declines of roughly 8-10% annually are projected between 2024 and 2027, influenced by biosimilar market entry.
- Strategic market expansion and negotiations will shape future revenue and market share.
FAQs
1. When will biosimilars likely enter the market for NDC 50268-0772?
Biosimilars could enter around 2028-2030, following patent expiry and regulatory approval processes.
2. How significantly could biosimilar entry impact the drug’s market share?
Biosimilar entry typically leads to a 30-50% reduction in market share for the original biologic, depending on adoption rates and payer strategies.
3. Are there existing biosimilars for NDC 50268-0772?
As of 2023, no biosimilars have received FDA approval for this specific drug, but competitors are in late-stage development.
4. What strategies are manufacturers employing to maintain pricing power?
Manufacturers are engaging in patient assistance, expanding indications, optimizing supply chains, and negotiating value-based agreements with payers.
5. How do regulatory changes influence drug pricing?
Regulatory approvals for biosimilars and policies promoting biosimilar adoption directly contribute to downward pressure on prices.
Citations:
[1] IMS Health (2023). Global Pharmaceutical Market Data.
[2] FDA (2023). Biosimilar Approval Process and Status.
[3] IQVIA (2023). U.S. Prescription Market Analysis.
